Roger Connor, departing GSK vaccines chief

GSK CEO Em­ma Walm­s­ley trig­gers ex­ec­u­tive team re­vamp as vac­cines chief Con­nor ex­its

GSK has more to re­port on this morn­ing than a shake­up in the on­col­o­gy pipeline. The phar­ma gi­ant tells me this morn­ing that Roger Con­nor, a 25-year vac­cine vet who’s been run­ning the di­vi­sion for the past four years, is on his way out to a new job in health­care — and they’re mak­ing some moves to in­te­grate the drugs and vac­cines ops un­der one um­brel­la in the post-con­sumer health spin­off phase.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.